MDIC’s first public summit devoted entirely to advancing the use of computational modeling and simulation (M&S) in the development and evaluation of medical devices.

This event will gather industry, researchers, regulators, and software companie to discuss how M&S could be used to provide regulatory-grade evidence of a device’s safety and efficacy. The summit is a unique opportunity for industry leaders to exchange ideas about how to leverage M&S to bring new devices to market safely, more quickly, and at lower cost—giving patients more and better choices for treatment.

Panel sessions and podium presentations will feature topics such as combining experiment and simulation to inform clinical trials, creating data repositories to support the industry-wide use of M&S, and much more.

Interact with experts in the field, including representatives from: ANSYS, BD (Becton, Dickinson, and Company), Boston Scientific, Dassault Systèmes Simulia, CBSET, J&J, DePuy Synthes, Exponent, FEAdvantage, FEops, IT’IS, Georgia Tech, Granta Design, HeartFlow, Materialise, Mayo Clinic, Medtronic, Open Source Medical Software Corporation, Simpleware, SynCardia Systems, St. Jude Medical, Stony Brook University, U.S. Food and Drug Administration, University of California, San Francisco, University of Arizona, University of Minnesota, Veryst Engineering, VEXTEC, Zimmer

  • Dawn Bardot, Senior Program Manager, Modeling and Simulation, MDIC
  • Tina Morrison, Advisor of Computational Modeling, Office of Device Evaluation, FDA
  • Kyle Myers, Director of the Division of Imaging and Applied Mathematics, Office of Science and Engineering Laboratories, FDA
  • Randy Schiestl, Vice President, Global Technology, Boston Scientific Corporation

Click here for RegistrationDirections, and a list of nearby Hotels. The summit is open to the public, but space is limited. Registration is $50. Please bring a photo ID and check in at the security desk.

Summit Location: The Pew Charitable Trusts | 901 E Street NW | Washington, D.C.

Please email with questions about the summit.

Download final agenda

Thursday, June 26

8:30 a.m. — 9:00 a.m. | Coffee reception

9:00 a.m. — 9:10 a.m. | Opening remarks

9:10 a.m. — 9:30 a.m. | Success story: In silico clinical trials

9:30 a.m. — 11:30 a.m. | Simulation of the heart, vasculature, and related medical devices. Track chair: Wei Gan, Medtronic

11:30 a.m. — 12:45 p.m. | 3 slides, 5 minutes: Snapshots of innovation in modeling and simulation. Track chair: James Coburn, FDA

12:45 p.m. — 1:55 p.m. | Simulation of blood damage and hemolysis. Track chair: Marc Horner, ANSYS

1:55 p.m. — 3:25 p.m.  | Magnetic resonance induced heating. Track chair: Victor Krauthamer, FDA

3:25 p.m. — 5:00 p.m. | Knowledge base repositories, validation data, and best practices. Track chair: David Flynn, Boston Scientific

Friday, June 27

8:30 a.m. — 9:00 a.m. | Coffee reception

9:00 a.m. — 9:20 a.m. | Ways to create exemplars: Mock submissions, FDA

9:20 a.m. — 10:55 a.m. | Powering clinical trials with simulation and bench testing. Track chair: Adam Hines, Medtronic

10:55 a.m. — 12:15 p.m. | Views from medical doctors on the future of modeling and simulation in health care. Track Chair: Tina Morrison, FDA

12:15 p.m. — 1:45 p.m. | 3 slides, 5 minutes: Snapshots of innovation in modeling and simulation. Track Chair: Zane Wyatt, FDA

1:45 p.m. — 3:25 p.m. | Modeling and Simulation in Orthopedics. Track Chair: Payman Afshari, Johnson & Johnson

3:25 p.m. — 4:00 p.m. | Interactive session & closing remarks. Track Chair: Dawn Bardot, MDIC